Philip Morris International Inc. vs Ventas Inc. Common Stock — how do they compare? Philip Morris International Inc. trades at $200.2 (market cap $312.50B), while Ventas Inc. Common Stock trades at $82.53 (market cap $41.94B). The key difference: Philip Morris International Inc. is far larger — about 7.5× Ventas Inc. Common Stock's market cap, and Philip Morris International Inc. pays the higher dividend (3.19%). Which is the better fit depends on your goals — on Pluang, investors hold Philip Morris International Inc. for 85 Days and Ventas Inc. Common Stock for 0 Days on average.
| PM | VTR | |
|---|---|---|
Market Cap | $312.50B | $41.94B |
Volume | 5,517,172 | 4,588,793 |
Sector | Consumer Staples | Real Estate |
52-Week High | $200.50 | $100.53 |
52-Week Low | $144.33 | $67.45 |
Typical Hold Time | 85 Days | 0 Days |
Enterprise Value | $355.62B | $54.66B |
Dividend Yield | 3.19% | 2.54% |
Signals from Pluang's Aura AI — not financial advice
Philip Morris International (PM) trades at $200.5, up 5.3% over 24 hours, with a bullish technical signal and strong earnings beats in Q1 and Q2 2026. The company shows robust fundamentals with 2025 revenue of $40.65B and net income of $11.35B, supported by a 67.48% gross margin. Recent news highlights expansion of smoke-free products like ZYN and IQOS, now over 40% of revenue, driving growth amid industry shifts.
Outlook is positive with analyst consensus at Buy (68%) and a $212.17 price target, though elevated P/E of 26.46 and regulatory risks in tobacco remain concerns. Earnings growth and smoke-free product adoption are key catalysts, but investors should monitor debt levels and competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.
Read more on VTR →